Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiology | 23 | 2022 | 164 | 2.390 |
Why?
|
Cardiac Catheterization | 20 | 2014 | 239 | 1.580 |
Why?
|
Angioplasty, Balloon, Coronary | 26 | 2014 | 165 | 1.540 |
Why?
|
Angioplasty | 4 | 2012 | 46 | 0.900 |
Why?
|
Coronary Angiography | 19 | 2015 | 168 | 0.780 |
Why?
|
Heart Valve Prosthesis Implantation | 8 | 2014 | 147 | 0.740 |
Why?
|
Stents | 7 | 2010 | 433 | 0.680 |
Why?
|
Coronary Disease | 14 | 2002 | 249 | 0.610 |
Why?
|
Coronary Artery Disease | 9 | 2015 | 266 | 0.600 |
Why?
|
Clinical Competence | 11 | 2014 | 669 | 0.540 |
Why?
|
Hospitals | 6 | 2014 | 373 | 0.510 |
Why?
|
Societies, Medical | 11 | 2013 | 326 | 0.500 |
Why?
|
Myocardial Infarction | 9 | 2009 | 855 | 0.470 |
Why?
|
Coronary Vessels | 8 | 2012 | 108 | 0.470 |
Why?
|
Coronary Artery Bypass | 10 | 2010 | 273 | 0.440 |
Why?
|
Mitral Valve | 4 | 2014 | 101 | 0.430 |
Why?
|
Heart Valve Diseases | 4 | 2014 | 86 | 0.430 |
Why?
|
Aortic Valve Stenosis | 5 | 2014 | 167 | 0.430 |
Why?
|
Patient Selection | 7 | 2011 | 443 | 0.390 |
Why?
|
Cardiovascular Agents | 3 | 2007 | 99 | 0.360 |
Why?
|
Patient Care Team | 8 | 2014 | 315 | 0.320 |
Why?
|
Carotid Stenosis | 1 | 2010 | 105 | 0.310 |
Why?
|
Radiology, Interventional | 3 | 2011 | 27 | 0.290 |
Why?
|
Treatment Outcome | 22 | 2022 | 5129 | 0.290 |
Why?
|
Thrombolytic Therapy | 5 | 2007 | 180 | 0.290 |
Why?
|
Medical Informatics | 1 | 2008 | 68 | 0.290 |
Why?
|
Patient Education as Topic | 2 | 2008 | 446 | 0.280 |
Why?
|
Humans | 70 | 2022 | 59047 | 0.280 |
Why?
|
Quality Assurance, Health Care | 3 | 2014 | 244 | 0.270 |
Why?
|
Practice Guidelines as Topic | 5 | 2014 | 701 | 0.270 |
Why?
|
Attitude of Health Personnel | 2 | 2007 | 556 | 0.270 |
Why?
|
Public Health | 1 | 2007 | 180 | 0.260 |
Why?
|
Thrombosis | 2 | 2007 | 193 | 0.260 |
Why?
|
Acute Coronary Syndrome | 3 | 2013 | 256 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2007 | 738 | 0.250 |
Why?
|
Health Policy | 3 | 2016 | 184 | 0.240 |
Why?
|
Coitus | 1 | 2004 | 17 | 0.230 |
Why?
|
Internet | 1 | 2008 | 455 | 0.230 |
Why?
|
Physician-Patient Relations | 1 | 2007 | 381 | 0.230 |
Why?
|
Risk Assessment | 11 | 2015 | 1900 | 0.220 |
Why?
|
American Heart Association | 6 | 2014 | 127 | 0.210 |
Why?
|
Health Promotion | 1 | 2007 | 490 | 0.210 |
Why?
|
Evidence-Based Medicine | 8 | 2012 | 455 | 0.210 |
Why?
|
Obesity, Morbid | 1 | 2004 | 90 | 0.210 |
Why?
|
Cardiovascular System | 1 | 2022 | 40 | 0.190 |
Why?
|
United States | 15 | 2016 | 7458 | 0.190 |
Why?
|
Program Development | 4 | 2014 | 210 | 0.180 |
Why?
|
Graft Occlusion, Vascular | 2 | 2010 | 60 | 0.180 |
Why?
|
Ambulatory Care | 2 | 2015 | 296 | 0.180 |
Why?
|
Risk Factors | 11 | 2011 | 4988 | 0.170 |
Why?
|
Cardiovascular Diseases | 4 | 2010 | 826 | 0.170 |
Why?
|
Radiography, Interventional | 2 | 2011 | 67 | 0.170 |
Why?
|
Coronary Thrombosis | 2 | 2007 | 23 | 0.170 |
Why?
|
Occupational Exposure | 3 | 2011 | 306 | 0.170 |
Why?
|
Women's Health | 3 | 2015 | 390 | 0.170 |
Why?
|
Hemorrhage | 2 | 2000 | 276 | 0.160 |
Why?
|
Ultrasonography, Interventional | 4 | 2013 | 85 | 0.160 |
Why?
|
Postoperative Complications | 4 | 2012 | 1123 | 0.160 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1999 | 33 | 0.160 |
Why?
|
Registries | 7 | 2010 | 802 | 0.160 |
Why?
|
Myocardial Revascularization | 4 | 2010 | 70 | 0.160 |
Why?
|
Male | 36 | 2013 | 27385 | 0.160 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2007 | 249 | 0.150 |
Why?
|
Quality of Health Care | 6 | 2012 | 514 | 0.150 |
Why?
|
Middle Aged | 28 | 2015 | 16190 | 0.140 |
Why?
|
Heart Ventricles | 1 | 1999 | 247 | 0.140 |
Why?
|
Health Facilities | 2 | 2014 | 43 | 0.140 |
Why?
|
Quality Improvement | 2 | 2011 | 412 | 0.130 |
Why?
|
Female | 34 | 2015 | 30684 | 0.130 |
Why?
|
Medical Staff Privileges | 5 | 2014 | 9 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 114 | 0.120 |
Why?
|
Terminology as Topic | 2 | 2013 | 138 | 0.120 |
Why?
|
Clinical Decision-Making | 1 | 2015 | 137 | 0.120 |
Why?
|
Abnormalities, Radiation-Induced | 2 | 2011 | 2 | 0.120 |
Why?
|
Radiation Monitoring | 2 | 2011 | 5 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2011 | 25 | 0.120 |
Why?
|
Certification | 1 | 2014 | 48 | 0.110 |
Why?
|
Radiation Protection | 2 | 2011 | 23 | 0.110 |
Why?
|
Time Factors | 8 | 2012 | 3552 | 0.110 |
Why?
|
Fetus | 2 | 2011 | 97 | 0.110 |
Why?
|
Electrocardiography | 5 | 2009 | 521 | 0.110 |
Why?
|
Radiation Dosage | 2 | 2011 | 121 | 0.110 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2013 | 12 | 0.110 |
Why?
|
Documentation | 1 | 2014 | 127 | 0.110 |
Why?
|
Sex Factors | 6 | 2010 | 957 | 0.110 |
Why?
|
Prosthesis Design | 3 | 2010 | 201 | 0.110 |
Why?
|
Angiography | 4 | 2004 | 145 | 0.110 |
Why?
|
Patient Care | 1 | 2013 | 76 | 0.100 |
Why?
|
Knowledge Bases | 4 | 2012 | 4 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2007 | 662 | 0.100 |
Why?
|
Pulmonary Wedge Pressure | 2 | 1991 | 24 | 0.100 |
Why?
|
Endarterectomy, Carotid | 2 | 2010 | 87 | 0.100 |
Why?
|
Thoracic Injuries | 1 | 1991 | 48 | 0.090 |
Why?
|
Quality Indicators, Health Care | 2 | 2011 | 328 | 0.090 |
Why?
|
Coronary Vessel Anomalies | 1 | 1991 | 15 | 0.090 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2013 | 152 | 0.090 |
Why?
|
Wounds, Nonpenetrating | 1 | 1991 | 106 | 0.090 |
Why?
|
Saphenous Vein | 1 | 2010 | 43 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2011 | 98 | 0.090 |
Why?
|
Algorithms | 1 | 2015 | 984 | 0.090 |
Why?
|
Heart Atria | 1 | 1991 | 137 | 0.090 |
Why?
|
Length of Stay | 4 | 2009 | 761 | 0.090 |
Why?
|
Career Choice | 3 | 2022 | 107 | 0.090 |
Why?
|
Mitral Valve Insufficiency | 1 | 1991 | 74 | 0.090 |
Why?
|
Primary Health Care | 1 | 2015 | 641 | 0.090 |
Why?
|
Women's Health Services | 1 | 2010 | 31 | 0.080 |
Why?
|
Stroke | 2 | 2010 | 1135 | 0.080 |
Why?
|
Women | 1 | 2010 | 46 | 0.080 |
Why?
|
Aged | 20 | 2012 | 13264 | 0.080 |
Why?
|
Research Design | 1 | 2013 | 564 | 0.080 |
Why?
|
Pregnancy | 3 | 2011 | 2334 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2011 | 164 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 1991 | 119 | 0.080 |
Why?
|
Occupational Health | 1 | 2011 | 186 | 0.080 |
Why?
|
Multivariate Analysis | 5 | 2007 | 925 | 0.080 |
Why?
|
Atherectomy, Coronary | 3 | 2003 | 10 | 0.080 |
Why?
|
Follow-Up Studies | 9 | 2002 | 2317 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2011 | 264 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2010 | 1444 | 0.080 |
Why?
|
Patient Readmission | 1 | 2012 | 416 | 0.070 |
Why?
|
Oxygen | 1 | 2009 | 307 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2010 | 295 | 0.070 |
Why?
|
Hypothermia, Induced | 1 | 2007 | 41 | 0.070 |
Why?
|
Drug-Eluting Stents | 1 | 2007 | 48 | 0.070 |
Why?
|
Contrast Media | 1 | 2009 | 405 | 0.070 |
Why?
|
Peptides | 2 | 2002 | 547 | 0.070 |
Why?
|
Coated Materials, Biocompatible | 1 | 2007 | 41 | 0.070 |
Why?
|
Coronary Restenosis | 2 | 2003 | 19 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 1022 | 0.070 |
Why?
|
Myocardial Ischemia | 3 | 2002 | 108 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2010 | 328 | 0.070 |
Why?
|
Prospective Studies | 6 | 2015 | 3079 | 0.060 |
Why?
|
Advisory Committees | 3 | 2013 | 107 | 0.060 |
Why?
|
Anticoagulants | 2 | 2000 | 485 | 0.060 |
Why?
|
Observer Variation | 2 | 2012 | 201 | 0.060 |
Why?
|
Fibrinolytic Agents | 2 | 2000 | 164 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2008 | 170 | 0.060 |
Why?
|
Patient Discharge | 1 | 2009 | 477 | 0.060 |
Why?
|
Credentialing | 1 | 2005 | 15 | 0.060 |
Why?
|
Vascular Patency | 3 | 2010 | 133 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2005 | 62 | 0.060 |
Why?
|
Oximes | 2 | 1994 | 11 | 0.060 |
Why?
|
Organotechnetium Compounds | 2 | 1994 | 28 | 0.060 |
Why?
|
Adult | 9 | 2011 | 15669 | 0.050 |
Why?
|
Cholesterol | 2 | 2002 | 256 | 0.050 |
Why?
|
Physicians | 1 | 2008 | 428 | 0.050 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 49 | 0.050 |
Why?
|
Echocardiography | 2 | 1999 | 455 | 0.050 |
Why?
|
Angioplasty, Balloon | 1 | 2002 | 56 | 0.050 |
Why?
|
Lipoproteins | 1 | 2002 | 85 | 0.050 |
Why?
|
Retirement | 1 | 2022 | 17 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2004 | 894 | 0.050 |
Why?
|
Stroke Volume | 3 | 2001 | 317 | 0.050 |
Why?
|
Hemodynamics | 3 | 1996 | 217 | 0.050 |
Why?
|
Angina Pectoris | 4 | 2002 | 36 | 0.050 |
Why?
|
Career Mobility | 1 | 2022 | 60 | 0.050 |
Why?
|
Heparin | 2 | 1999 | 113 | 0.050 |
Why?
|
Survival Rate | 2 | 2000 | 788 | 0.050 |
Why?
|
Disease Management | 2 | 2013 | 219 | 0.050 |
Why?
|
Pain | 1 | 2004 | 406 | 0.050 |
Why?
|
Streptokinase | 1 | 2000 | 6 | 0.050 |
Why?
|
Curriculum | 2 | 2013 | 543 | 0.040 |
Why?
|
Platelet Count | 1 | 2000 | 33 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 2 | 2014 | 243 | 0.040 |
Why?
|
Salvage Therapy | 1 | 2000 | 75 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 2 | 2010 | 32 | 0.040 |
Why?
|
Benchmarking | 2 | 2011 | 134 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2000 | 80 | 0.040 |
Why?
|
Diffusion of Innovation | 2 | 2010 | 55 | 0.040 |
Why?
|
Constriction, Pathologic | 3 | 1994 | 99 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2000 | 124 | 0.040 |
Why?
|
Consensus | 2 | 2011 | 190 | 0.040 |
Why?
|
Myocardial Contraction | 1 | 1999 | 83 | 0.040 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 300 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 1998 | 115 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 1998 | 63 | 0.040 |
Why?
|
Risk | 2 | 2012 | 370 | 0.040 |
Why?
|
Age Factors | 1 | 2000 | 1518 | 0.030 |
Why?
|
Rest | 1 | 1994 | 43 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 1994 | 67 | 0.030 |
Why?
|
Fish Oils | 1 | 1994 | 43 | 0.030 |
Why?
|
Diastole | 1 | 1994 | 89 | 0.030 |
Why?
|
Policy Making | 1 | 2014 | 51 | 0.030 |
Why?
|
Coronary Circulation | 1 | 1994 | 50 | 0.030 |
Why?
|
Educational Status | 1 | 1995 | 270 | 0.030 |
Why?
|
Incidence | 2 | 2002 | 1232 | 0.030 |
Why?
|
Analysis of Variance | 1 | 1994 | 576 | 0.030 |
Why?
|
Radiography | 1 | 1995 | 505 | 0.030 |
Why?
|
Learning Curve | 1 | 2013 | 23 | 0.030 |
Why?
|
Foundations | 1 | 2013 | 8 | 0.030 |
Why?
|
Research Report | 1 | 2013 | 28 | 0.030 |
Why?
|
Logistic Models | 3 | 2002 | 1247 | 0.030 |
Why?
|
Education, Medical | 2 | 2010 | 175 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 696 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 1995 | 435 | 0.020 |
Why?
|
Health Physics | 1 | 2011 | 5 | 0.020 |
Why?
|
X-Rays | 1 | 2011 | 44 | 0.020 |
Why?
|
Argentina | 1 | 2010 | 6 | 0.020 |
Why?
|
Radiometry | 1 | 2011 | 34 | 0.020 |
Why?
|
Insurance, Health | 1 | 2012 | 141 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2002 | 232 | 0.020 |
Why?
|
Brazil | 1 | 2010 | 85 | 0.020 |
Why?
|
Research Subjects | 1 | 1991 | 38 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 1991 | 100 | 0.020 |
Why?
|
Swine | 2 | 1994 | 337 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2011 | 158 | 0.020 |
Why?
|
Informed Consent | 1 | 1991 | 133 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2009 | 42 | 0.020 |
Why?
|
Troponin | 1 | 2009 | 37 | 0.020 |
Why?
|
Data Collection | 1 | 2011 | 384 | 0.020 |
Why?
|
Observation | 1 | 2009 | 28 | 0.020 |
Why?
|
Cohort Studies | 1 | 2015 | 2429 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 1989 | 30 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 1989 | 17 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2009 | 108 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 1989 | 38 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2009 | 43 | 0.020 |
Why?
|
Mentors | 1 | 2010 | 113 | 0.020 |
Why?
|
Heart Diseases | 1 | 2010 | 204 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2009 | 134 | 0.020 |
Why?
|
Quality of Life | 1 | 1995 | 1103 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 807 | 0.020 |
Why?
|
Health Care Costs | 1 | 2009 | 200 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2002 | 105 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2007 | 95 | 0.020 |
Why?
|
Blood Platelets | 1 | 1989 | 176 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 171 | 0.020 |
Why?
|
Child | 1 | 1996 | 4258 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 2012 | 709 | 0.020 |
Why?
|
Recurrence | 3 | 1994 | 575 | 0.020 |
Why?
|
Pyrrolidines | 1 | 1985 | 13 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2010 | 542 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 1985 | 54 | 0.020 |
Why?
|
Catheterization | 1 | 2005 | 109 | 0.010 |
Why?
|
Biomarkers | 1 | 2009 | 1202 | 0.010 |
Why?
|
Prosthesis Implantation | 1 | 2003 | 30 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2007 | 277 | 0.010 |
Why?
|
Belgium | 1 | 2002 | 6 | 0.010 |
Why?
|
Quebec | 1 | 2002 | 12 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2002 | 78 | 0.010 |
Why?
|
Equipment Design | 1 | 2002 | 313 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2003 | 519 | 0.010 |
Why?
|
Animals | 3 | 2007 | 19549 | 0.010 |
Why?
|
Triglycerides | 1 | 2002 | 245 | 0.010 |
Why?
|
Prognosis | 2 | 2002 | 1563 | 0.010 |
Why?
|
Double-Blind Method | 2 | 1994 | 683 | 0.010 |
Why?
|
Cognition | 1 | 2005 | 458 | 0.010 |
Why?
|
Acute Disease | 1 | 2002 | 654 | 0.010 |
Why?
|
Regression Analysis | 1 | 2001 | 485 | 0.010 |
Why?
|
Pilot Projects | 1 | 2003 | 913 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2001 | 160 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 553 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2000 | 51 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2001 | 675 | 0.010 |
Why?
|
Treatment Failure | 1 | 2000 | 188 | 0.010 |
Why?
|
Whole Blood Coagulation Time | 1 | 1999 | 3 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2002 | 5950 | 0.010 |
Why?
|
Emergencies | 1 | 2000 | 114 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2000 | 152 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 170 | 0.010 |
Why?
|
Blood Vessels | 1 | 1999 | 61 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1999 | 280 | 0.010 |
Why?
|
Blood Coagulation | 1 | 1998 | 50 | 0.010 |
Why?
|
Massachusetts | 1 | 2002 | 2082 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1995 | 58 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2000 | 841 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1994 | 116 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 104 | 0.010 |
Why?
|
Heart Failure | 1 | 2000 | 860 | 0.010 |
Why?
|
Heart | 1 | 1994 | 274 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 1995 | 419 | 0.010 |
Why?
|
Therapeutic Human Experimentation | 1 | 1991 | 5 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1993 | 191 | 0.010 |
Why?
|
Consent Forms | 1 | 1991 | 15 | 0.010 |
Why?
|
Forecasting | 1 | 1992 | 218 | 0.010 |
Why?
|
Reoperation | 1 | 1992 | 248 | 0.010 |
Why?
|
Comprehension | 1 | 1991 | 126 | 0.010 |
Why?
|
Smoking | 1 | 1994 | 831 | 0.010 |
Why?
|
Apolipoproteins B | 1 | 1989 | 21 | 0.010 |
Why?
|
Perfusion | 1 | 1986 | 77 | 0.000 |
Why?
|
Bepridil | 1 | 1985 | 1 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1985 | 18 | 0.000 |
Why?
|
Cardiac Output | 1 | 1985 | 33 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1985 | 44 | 0.000 |
Why?
|
Heart Rate | 1 | 1985 | 303 | 0.000 |
Why?
|
Blood Pressure | 1 | 1985 | 518 | 0.000 |
Why?
|